TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics’ Unique HTG EdgeSeq System

- December 5th, 2018

TATAA Biocenter, Europe’s leading provider of genomic services, and HTG Molecular Diagnostics (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the expansion of TATAA Biocenter’s next-generation sequencing (NGS) offerings with HTG’s unique HTG EdgeSeq system. As quoted in the press release: “The HTG EdgeSeq system is a conceptual breakthrough … Continued

TATAA Biocenter, Europe’s leading provider of genomic services, and HTG Molecular Diagnostics (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the expansion of TATAA Biocenter’s next-generation sequencing (NGS) offerings with HTG’s unique HTG EdgeSeq system.

As quoted in the press release:

“The HTG EdgeSeq system is a conceptual breakthrough in targeted RNA sequencing offering superior sensitivity and specificity to traditional RNASeq approaches,” said Dr. Mikael Kubista, founder and CEO of TATAA Biocenter. “We have validated the HTG EdgeSeq system in the European CANCER-ID consortium (www.cancer-id.eu), and we are proud to be among the first in Europe offering RNA sequencing service with this new platform.”

Jean Claude Gerard, HTG’s Vice President of European Operations stated, “HTG is thrilled to partner with TATAA Biocenter on extending TATAA’s current genomic service and hands-on NGS training course offerings. With the growing need for broad and reproducible gene-expression analysis from ever decreasing sample sizes, HTG’s extraction-free HTG EdgeSeq technology enables sensitive profiling of very limited samples. We believe these capabilities will open new perspectives in the field of liquid biopsy and tumor profiling and help advance precision medicine.” Mr. Gerard concluded, “A key to making this happen is HTG, as a technology provider, making education and training one of its key missions. Joining forces with TATAA Biocenter reflects a next step in our ongoing commitment to this effort.”

Click here to read the full press release.

Are gold stocks a good idea for 2019?


Get your free market forecast today

Leave a Reply

Your email address will not be published. Required fields are marked *